23andMe co-founder Anne Wojcicki is back at the helm. Wojcicki, who stepped down as 23andMe CEO in March, leads a nonprofit called TTAM — the first letters of 23andMe. TTAM is the new buyer for ...

Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...

The medical research nonprofit vying to buy 23andMe is informing existing customers that it plans to complete the deal on July 8.… Founded by 23andMe's former CEO and co-founder Anne Wojcicki, TTAM ...

The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...

23andMe co-founder and former CEO Anne Wojcicki has agreed to repurchase the bankrupt genetics firm for $305 million, after her nonprofit outbid pharmaceutical giant Regeneron in a court-supervised ...

With a purchase price of $256 million, some investors might think the valuation is a bit rich for a business in such a dire position as 23andMe, but it won't put a huge dent into Regeneron's ...

Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday. 23andMe filed for Chapter 11 bankruptcy protection in March. Last month, ...

23andMe's interim chief executive Joseph Selsavage told lawmakers on Tuesday that 1.9 million people, or about 15% of its customer base, have requested their genetic data be deleted from the company's ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 23andMe bought high — as Covid ...

The Good Liars, hungover, discuss Pete Hegseth and company’s war-planning on Signal, the sale of 23andMe, and advice for ...

In a court filing, 23andMe is seeking court approval to allow former CEO Anne Wojcicki and Regeneron to submit final proposals by June 12. (23andMe) The bidding competition over 23andMe may not be ...

Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information. Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S.